Event Begins: Thursday, November 14, 2024 4:00pm
Location:
Organized By: University Career Center

Info Session: Amgen Undergrad Finance Internship Summer 2025 Please join the Amgen corporate finance team for a virtual presentation to learn more about our undergraduate finance internship and biotechnology company. Our summer internship gives students the opportunity to own business-critical projects, participate in a case competition with fellow interns, network with company executives,and much more. Please see event details below. We look forward to meetingyou! Info Session: Amgen Corporate Finance Internship Summer 2025Where: via Teams linkWhen: Thursday, Nov. 14th at 4:00-5:00pm PSTTo apply or to learn more about the internship, search Job ID #R-195767 at careers.amgen.com. Amgen is one of the world’s leading biotechnology companies. With a foundation of strong values, Amgen uses science and innovation to transform insights into medicines for patients with serious illnesses. Our mission is to serve patients and we embody this in every initiative, goal and task. When you join our team, you’ll make a positive impact in the world.

The Amgen Biotech Experience empowers teachers to bring biotechnology into their classrooms to spark students� love of science and features a hands-on curriculum that introduces students to the excitement of scientific discovery.

Amgen Scientists Visit Biotechnology Classrooms Across the Country in Support of National Lab Day

The US food and Drug Administration has announced that it has approved Amgen's supplemental new drug application for Kyprolis in combination with dexamethasone

(United States Federal Circuit) - Returning once again after climbing and descending the appellate ladder several times, the court held that the defendant had not forfeited its preemption defense and that the Biologics Price Competition and Innovation Act preempts state law remedies for an applicant's failure to comply with aspects of the Act, and affirming the dismissal of the state law claims.

Psoriasis therapy may be a potential treatment for COVID-19

The US District Court in Delaware issued a decision upholding the validity of patent claims from three…

Amgen is planning to file for FDA approval of Otezla in mild to moderate plaque psoriasis based on new data showing patients on the drug experienced significant improvements in their symptoms. The label expansion will be key to Amgen's ability to recoup the $13.4 billion it paid to acquire the drug from Celgene last year.

Earlier today, at the federal courthouse in Brooklyn, New York, U.S. District Judge Sterling Johnson, Jr. accepted a guilty plea by American biotechnology giant Amgen Inc. (Amgen) for illegally introducing a misbranded drug into interstate commerce. The plea is part of a global settlement with the United States in which Amgen agreed to pay $762 million to resolve criminal and civil liability arising from its sale and promotion of certain drugs. The settlement represents the single largest criminal and civil False Claims Act settlement involving a biotechnology company in U.S. history.

Amgen Inc., a California-based biotechnology company, has agreed to pay the United States $24.9 million to settle allegations that it violated the False Claims Act.

The Amgen Biotech Experience empowers teachers to bring biotechnology into their classrooms to spark students’ love of science and features a hands-on curriculum that introduces students to the excitement of scientific discovery.